Q2 2025 Holdings
Filed 2025-08-14 | 175 holdings | $4.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $314.8M | 571,039 | 6.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $310.3M | 7,853,198 | 6.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $228.8M | 1,820,000 | 5.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $220.6M | 676,367 | 4.9% |
| Abbott Labs(ABT) | COM | 002824100 | $212.7M | 1,564,022 | 4.7% |
| Stryker Corporation(SYK) | COM | 863667101 | $211.7M | 535,089 | 4.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $205.8M | 378,728 | 4.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $196.6M | 441,610 | 4.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $189.6M | 1,765,194 | 4.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $168.5M | 4,579,300 | 3.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $119.4M | 3,590,150 | 2.6% |
| Incyte Corp(INCY) | COM | 45337C102 | $106.9M | 1,570,333 | 2.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $105.9M | 1,985,272 | 2.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $104.4M | 2,947,295 | 2.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $80.3M | 921,043 | 1.8% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $76.6M | 2,441,830 | 1.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $75.1M | 860,828 | 1.7% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $69.5M | 889,077 | 1.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $68.8M | 219,013 | 1.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $67.3M | 3,307,569 | 1.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $54.6M | 316,732 | 1.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $49.1M | 2,889,288 | 1.1% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $46.0M | 113,544 | 1.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $44.7M | 174,050 | 1.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $44.4M | 142,296 | 1.0% |
| Resmed Inc(RMD) | COM | 761152107 | $42.8M | 165,802 | 0.9% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $41.1M | 76,548 | 0.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $39.5M | 2,802,853 | 0.9% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $38.2M | 515,468 | 0.8% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $38.0M | 99,122 | 0.8% |
| The Cigna Group(CI) | COM | 125523100 | $36.6M | 110,712 | 0.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $36.5M | 284,900 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $36.4M | 2,775,997 | 0.8% |
| Moderna Inc(MRNA) | COM | 60770K107 | $34.2M | 1,238,668 | 0.8% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $32.6M | 113,333 | 0.7% |
| Elevance Health Inc(ELV) | COM | 036752103 | $31.9M | 82,053 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $31.9M | 40,920 | 0.7% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $29.7M | 40,466 | 0.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $29.6M | 159,661 | 0.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $28.5M | 150,787 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $28.5M | 8,230,870 | 0.6% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $28.2M | 489,278 | 0.6% |
| Danaher Corporation(DHR) | COM | 235851102 | $27.0M | 136,811 | 0.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $26.6M | 4,094,458 | 0.6% |
| Steris PLC(STE) | SHS USD | G8473T100 | $26.4M | 109,887 | 0.6% |
| Cooper COS Inc(COO) | COM | 216648501 | $25.3M | 356,074 | 0.6% |
| Natera Inc(NTRA) | COM | 632307104 | $24.9M | 147,491 | 0.5% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $24.4M | 267,716 | 0.5% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $22.1M | 74,022 | 0.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $19.6M | 332,336 | 0.4% |